ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,825 | -35.8% | 23,604 | +0.7% | 0.00% | – |
Q2 2023 | $116,517 | +0.6% | 23,444 | 0.0% | 0.00% | – |
Q1 2023 | $115,813 | -21.5% | 23,444 | 0.0% | 0.00% | – |
Q4 2022 | $147,463 | -41.2% | 23,444 | +0.8% | 0.00% | -100.0% |
Q3 2022 | $251,000 | -5.3% | 23,254 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $265,000 | +25.6% | 23,254 | +0.3% | 0.00% | – |
Q1 2022 | $211,000 | -39.0% | 23,184 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $346,000 | -40.7% | 23,184 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $583,000 | -1.5% | 22,684 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $592,000 | -22.3% | 22,684 | +5.0% | 0.00% | -50.0% |
Q1 2021 | $762,000 | +37.8% | 21,597 | -1.4% | 0.00% | +100.0% |
Q4 2020 | $553,000 | -33.1% | 21,897 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $826,000 | +6.4% | 21,897 | +20.8% | 0.00% | 0.0% |
Q2 2020 | $776,000 | +219.3% | 18,127 | +93.8% | 0.00% | +100.0% |
Q4 2019 | $243,000 | +4.7% | 9,355 | +10.1% | 0.00% | 0.0% |
Q3 2019 | $232,000 | +1.8% | 8,495 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $228,000 | – | 8,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $11,310,445 | 15.20% |
Wildcat Capital Management, LLC | 2,128,370 | $13,387,447 | 5.11% |
TPG GP A, LLC | 18,716,306 | $117,725,565 | 2.31% |
EcoR1 Capital, LLC | 4,488,200 | $28,230,778 | 0.86% |
Coastal Bridge Advisors, LLC | 406,847 | $2,559,068 | 0.73% |
Kynam Capital Management, LP | 396,378 | $2,493,218 | 0.38% |
AXQ CAPITAL, LP | 73,052 | $459,497 | 0.32% |
Pier Capital, LLC | 262,832 | $1,653,213 | 0.27% |
HARBOR CAPITAL ADVISORS, INC. | 41,801 | $262,928 | 0.26% |
Woodline Partners LP | 2,921,462 | $18,375,996 | 0.25% |